Triple-negative breast cancer in association with RAD51C pathogenic variants

被引:0
|
作者
Blatnik, Ana [1 ]
Strojnik, Ksenija [1 ]
Banjac, Marta [1 ]
Stegel, Vida [2 ]
Dragos, Vita Setrajcic [2 ]
Skerl, Petra [2 ]
Klancar, Gasper [2 ]
Novakovic, Srdjan [2 ]
Krajc, Mateja [1 ]
机构
[1] Inst Oncol Ljubljana, Dept Oncol Clin Genet, Ljubljana, Slovenia
[2] Inst Oncol Ljubljana, Dept Mol Diagnost, Ljubljana, Slovenia
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
P13.077.C
引用
收藏
页码:551 / 551
页数:1
相关论文
共 50 条
  • [41] The association of metabolic syndrome with triple-negative breast cancer
    Maiti, B.
    Kundranda, M. N.
    Jin, T.
    Spiro, T. P.
    Daw, H. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [42] The association of metabolic syndrome with triple-negative breast cancer
    B. Maiti
    M. N. Kundranda
    T. P. Spiro
    H. A. Daw
    Breast Cancer Research and Treatment, 2010, 121 : 479 - 483
  • [43] The association of metabolic syndrome with triple-negative breast cancer
    Maiti, B.
    Kundranda, M. N.
    Spiro, T. P.
    Daw, H. A.
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 121 (02) : 479 - 483
  • [44] A description of women with the pathogenic variants in the ovarian cancer risk genes BRIP1, RAD51C, RAD51D identified through clinical testing by a hereditary cancer panel
    Usha, L.
    San Roman, S.
    Gorringe, H.
    Bernhisel, R.
    Brown, K.
    Saam, J.
    Manley, S.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 23 - 24
  • [45] BARD1 Pathogenic Variants Are Associated with Triple-Negative Breast Cancer in a Spanish Hereditary Breast and Ovarian Cancer Cohort
    Rofes, Paula
    Del Valle, Jesus
    Torres-Esquius, Sara
    Feliubadalo, Lidia
    Stradella, Agostina
    Moreno-Cabrera, Jose Marcos
    Lopez-Doriga, Adriana
    Munte, Elisabet
    De Cid, Rafael
    Campos, Olga
    Cuesta, Raquel
    Teule, Alex
    Grau, Elia
    Sanz, Judit
    Capella, Gabriel
    Diez, Orland
    Brunet, Joan
    Balmana, Judith
    Lazaro, Conxi
    GENES, 2021, 12 (02) : 1 - 11
  • [46] Integration of tumour sequencing and case–control data to assess pathogenicity of RAD51C missense variants in familial breast cancer
    Belle W. X. Lim
    Na Li
    Simone M. Rowley
    Ella R. Thompson
    Simone McInerny
    Magnus Zethoven
    Rodney J. Scott
    Lisa Devereux
    Erica K. Sloan
    Paul A. James
    Ian G. Campbell
    npj Breast Cancer, 8
  • [47] Metastatic Prostate Cancer in a RAD51C Mutation Carrier
    Potugari, Bindu R.
    Engel, Jessica M.
    Onitilo, Adedayo A.
    CLINICAL MEDICINE & RESEARCH, 2018, 16 (3-4) : 69 - 72
  • [48] Germline RAD51C mutations in ovarian cancer susceptibility
    Coulet, F.
    Fajac, A.
    Colas, C.
    Eyries, M.
    Dion-Miniere, A.
    Rouzier, R.
    Uzan, S.
    Lefranc, J-P
    Carbonnel, M.
    Cornelis, F.
    Cortez, A.
    Soubrier, F.
    CLINICAL GENETICS, 2013, 83 (04) : 332 - 336
  • [49] Mutation screening of RAD51C in high-risk breast and ovarian cancer families
    Wenping Lu
    Xianshu Wang
    Hongsheng Lin
    Noralane M. Lindor
    Fergus J. Couch
    Familial Cancer, 2012, 11 : 381 - 385
  • [50] Triple-Negative Breast Cancer
    Winkeljohn, Debra L.
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2008, 12 (06) : 861 - 863